Abstract

Selenium protects cells and tissues at the cellular level from damage caused by oxidative stress; This is especially true for heart disease, which remains the leading cause of death worldwide. We examined 77 women with metabolically healthy obesity (MHO) during the menopausal transition (MT), and established a connection between hypoestrogenemia and psychovegetative disorders, hypersympathicotonia, and cardialgia. It has been established that the natural non-hormonal drug SELENBIO for women has a positive effect on the psychovegetative status and episodes of cardialgia during MHO in women with estrogen deficiency during the MT. The drug SELENBIO for women has a complex, versatile effect on the female body, helps normalize hormonal levels and ovarian function, neutralizes clinical manifestations, has a general strengthening and immunomodulatory effect, and, thanks to its antioxidant effect at the cellular level, slows down the aging process. All components of the drug are physiologically close to the human body and do not disrupt the natural processes occurring in it. The drug SELENBIO for women is highly effective with low toxicity, has a wide spectrum of action, and has a complex harmonizing effect on the body.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.